Overview

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

Status:
Terminated

Trial end date:
2007-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the plasma levels of two different analgesic transdermal patch formulations lead to same plasma levels of the active ingredient after single dose application.

Phase:

Phase 1

Details

Lead Sponsor:

Grünenthal GmbH

Treatments:

Analgesics
Buprenorphine